335 related articles for article (PubMed ID: 16979156)
1. Selection of new chemical entities with decreased potential for adverse drug reactions.
Park KB; Dalton-Brown E; Hirst C; Williams DP
Eur J Pharmacol; 2006 Nov; 549(1-3):1-8. PubMed ID: 16979156
[TBL] [Abstract][Full Text] [Related]
2. Toxicophores: investigations in drug safety.
Williams DP
Toxicology; 2006 Sep; 226(1):1-11. PubMed ID: 16860917
[TBL] [Abstract][Full Text] [Related]
3. Are chemically reactive metabolites responsible for adverse reactions to drugs?
Williams DP; Kitteringham NR; Naisbitt DJ; Pirmohamed M; Smith DA; Park BK
Curr Drug Metab; 2002 Aug; 3(4):351-66. PubMed ID: 12093355
[TBL] [Abstract][Full Text] [Related]
4. Reactive Metabolites: Current and Emerging Risk and Hazard Assessments.
Thompson RA; Isin EM; Ogese MO; Mettetal JT; Williams DP
Chem Res Toxicol; 2016 Apr; 29(4):505-33. PubMed ID: 26735163
[TBL] [Abstract][Full Text] [Related]
5. The role of reactive drug metabolites in immune-mediated adverse drug reactions.
Hess DA; Rieder MJ
Ann Pharmacother; 1997 Nov; 31(11):1378-87. PubMed ID: 9391694
[TBL] [Abstract][Full Text] [Related]
6. Role of reactive metabolites in drug-induced hepatotoxicity.
Srivastava A; Maggs JL; Antoine DJ; Williams DP; Smith DA; Park BK
Handb Exp Pharmacol; 2010; (196):165-94. PubMed ID: 20020263
[TBL] [Abstract][Full Text] [Related]
7. Drug bioactivation, covalent binding to target proteins and toxicity relevance.
Zhou S; Chan E; Duan W; Huang M; Chen YZ
Drug Metab Rev; 2005; 37(1):41-213. PubMed ID: 15747500
[TBL] [Abstract][Full Text] [Related]
8. Understanding the role of reactive metabolites in drug-induced hepatotoxicity: state of the science.
Antoine DJ; Williams DP; Park BK
Expert Opin Drug Metab Toxicol; 2008 Nov; 4(11):1415-27. PubMed ID: 18950283
[TBL] [Abstract][Full Text] [Related]
9. [Drug damage to the liver: role of reactive metabolites and pharmacokinetics].
Lauterburg BH
Schweiz Med Wochenschr; 1985 Sep; 115(38):1306-12. PubMed ID: 3933110
[TBL] [Abstract][Full Text] [Related]
10. Metabolic activation in drug-induced liver injury.
Leung L; Kalgutkar AS; Obach RS
Drug Metab Rev; 2012 Feb; 44(1):18-33. PubMed ID: 21939431
[TBL] [Abstract][Full Text] [Related]
11. Detecting reactive drug metabolites for reducing the potential for drug toxicity.
Grillo MP
Expert Opin Drug Metab Toxicol; 2015; 11(8):1281-302. PubMed ID: 26005795
[TBL] [Abstract][Full Text] [Related]
12. Development and evaluation of an electrochemical method for studying reactive phase-I metabolites: correlation to in vitro drug metabolism.
Madsen KG; Olsen J; Skonberg C; Hansen SH; Jurva U
Chem Res Toxicol; 2007 May; 20(5):821-31. PubMed ID: 17447796
[TBL] [Abstract][Full Text] [Related]
13. [Reactive metabolites of xenobiotics : their role in the hepatotoxicity of drugs].
Pessayre D; Benhamou JP
C R Seances Soc Biol Fil; 1979; 173(2):458-68. PubMed ID: 159767
[TBL] [Abstract][Full Text] [Related]
14. Reactive metabolites as a cause of hepatotoxicity.
Prescott LF
Int J Clin Pharmacol Res; 1983; 3(6):437-41. PubMed ID: 6381340
[TBL] [Abstract][Full Text] [Related]
15. Managing the liabilities arising from structural alerts: a safe philosophy for medicinal chemists.
Edwards PJ; Sturino C
Curr Med Chem; 2011; 18(20):3116-35. PubMed ID: 21651480
[TBL] [Abstract][Full Text] [Related]
16. Drug bioactivation and protein adduct formation in the pathogenesis of drug-induced toxicity.
Park BK; Laverty H; Srivastava A; Antoine DJ; Naisbitt D; Williams DP
Chem Biol Interact; 2011 Jun; 192(1-2):30-6. PubMed ID: 20846520
[TBL] [Abstract][Full Text] [Related]
17. The role of metabolic activation in drug-induced hepatotoxicity.
Park BK; Kitteringham NR; Maggs JL; Pirmohamed M; Williams DP
Annu Rev Pharmacol Toxicol; 2005; 45():177-202. PubMed ID: 15822174
[TBL] [Abstract][Full Text] [Related]
18. Bioactivation and bound residues.
Burgat-Sacaze V; Rico A; Delatour P
Food Addit Contam; 1984; 1(2):121-9. PubMed ID: 6536524
[TBL] [Abstract][Full Text] [Related]
19. Application of CYP102A1M11H as a tool for the generation of protein adducts of reactive drug metabolites.
Boerma JS; Vermeulen NP; Commandeur JN
Chem Res Toxicol; 2011 Aug; 24(8):1263-74. PubMed ID: 21639118
[TBL] [Abstract][Full Text] [Related]
20. From toxic precursors to safe drugs. Mechanisms and relevance of idiosyncratic drug reactions.
Petersen KU
Arzneimittelforschung; 2002; 52(6):423-9. PubMed ID: 12109041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
